SC 13D/A

GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1

Company: X4 Pharmaceuticals, Inc
Filed: May 26, 2023
Accession Number: 0001072613-23-000346

View Document ↗ View on SEC.gov ↗